1-4 of 4
Seval Türkmen
Close
Sort by
Journal Articles

Increased MSI2 expression Is Associated with Aggressive CML and AML

Jaspal S Kaeda, PhD, FRCPath, Ken I. Mills, PhD, FRCPath, Michael G Kharas, PhD, Giuseppe Saglio, MD, Michaela Schwarz, MD, Christian Oberender, Bärbel Pawlaczyk-Peter, Antje van Lessen, Seval Türkmen, MD, Claudia D Baldus, MD, Frauke Ringel, PhD, Thomas Pretzsch, Peggy Grille, Anna Serra, PhD, Anne Carson, PhD, Mary Frances McMullin, MD, Jörg Westermann, MD, Peter Daniel, MD, PhD, Bernd Dörken, Philipp D. le Coutre, MD
Journal: Blood
Blood (2011) 118 (21): 2516.
https://doi.org/10.1182/blood.V118.21.2516.2516
Published: 2011
Journal Articles

A Novel BACH2 - BCL2L1 Fusion Gene in the Burkitt’s Lymphoma Derived Cell Line BLUE - 1

Seval Türkmen, Mathias Riehn, Stefan Mundlos, Eckhard Thiel, Thomas Burmeister
Journal: Blood
Blood (2008) 112 (11): 4146.
https://doi.org/10.1182/blood.V112.11.4146.4146
Published: 2008
Journal Articles

Acute Lymphoblastic Leukemia in a Case of Ring Chromosome

Seval Türkmen, Sebastian Muller, Stefan Mundlos, Günter Henze, Holger Lode
Journal: Blood
Blood (2008) 112 (11): 4151.
https://doi.org/10.1182/blood.V112.11.4151.4151
Published: 2008
Journal Articles

Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma

Clinical Trials & Observations
Christian Jakob, Karl Egerer, Peter Liebisch, Seval Türkmen, Ivana Zavrski, Ulrike Kuckelkorn, Ulrike Heider, Martin Kaiser, Claudia Fleissner, Jan Sterz, Lorenz Kleeberg, Eugen Feist, Gerd-R. Burmester, Peter-M. Kloetzel, Orhan Sezer
Journal: Blood
Blood (2006) 109 (5): 2100–2105.
https://doi.org/10.1182/blood-2006-04-016360
Published: 2006